Skip to main content

Table 1 Prevalence of CCS uptake across participants’ characteristics

From: Cervical cancer screening among women with comorbidities: evidence from the 2022 Tanzania demographic and health survey

Variables

Weighted sample [n (%)]

Yes, screened for cervical cancer

n (%)a

p-value

Having either one of the diseases

  

< 0.001

No

5323 (84.5)

529 (9.9)

 

Yes

975 (15.5)

276 (28.3)

 

Ever diagnosed of hypertension

 

< 0.001

No

5684 (90.3)

657 (11.6)

 

Yes

614 (9.7)

148 (24.1)

 

Positive HIV test result

  

< 0.001

No

587 (93.6)

658 (11.2)

 

Yes

401 (6.4)

147 (36.7)

 

History of STI within last 12 months

  

0.003

No

5927 (94.1)

748 (12.6)

 

Yes

371 (5.9)

57 (15.5)

 

Parity

  

< 0.001

Nulliparous

194 (3.1)

39 (19.9)

 

Uniparous

370 (5.9)

80 (21.5)

 

Multiparous

57,374 (91.0)

687 (11.9)

 

Age

  

< 0.001

30–34 years

1957 (31.1)

210 (10.7)

 

35–39 years

1747 (27.8)

214 (12.3)

 

40–44 years

1422 (22.5)

202 (14.2)

 

45–49 years

1171 (18.6)

178 (15.2)

 

Place of residence

  

< 0.001

Urban

2285 (36.3)

477 (20.9)

 

Rural

4013 (63.7)

328 (8.2)

 

Educational level

  

< 0.001

No education

1289 (20.5)

70 (5.4)

 

Primary

3950 (62.7)

494 (12.5)

 

Secondary

956 (15.2)

210 (21.9)

 

Higher

103 (1.6)

31 (30.0)

 

Media exposure

  

< 0.001

No

3444 (54.7)

295 (8.6)

 

Yes

2854 (45.3)

510 (17.9)

 

Wealth index

  

< 0.001

Lower

2010 (31.9)

101 (5.0)

 

Middle

1243 (19.7)

102 (8.2)

 

Higher

3045 (48.4)

602 (19.8)

 

Distance to health facility

  

< 0.001

Not a big problem

4415 (70.1)

650 (14.7)

 

Big problem

1883 (29.9)

155 (8.2)

 

Total

6298 (100.0)

805 (12.8)

 
  1. an(%) are row percentages